First cancer patient treated with a new experimental viral immunotherapy combination in a clinical trial
The Ottawa Hospital and Hamilton Health Sciences have begun a clinical trial to determine if an experimental therapy that combines two viruses and a drug may be able to treat non-small cell lung cancer. This approach is designed to stimulate the immune system to recognize and attack cancer cells while also killing the cancer directly. It is considered a kind of immunotherapy.
The first trial participant was recently treated at Hamilton Health Sciences. An additional 54 patients are expected to be enrolled in the trial and treated in Hamilton and Ottawa as well as other sites.
Read more
|